Complete Filing Data
Mirum Pharmaceuticals, Inc. reported Stockholders Equity of $314.69 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Mirum Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$23.4M | -$87.9M | -$163.4M | -$135.7M | -$84.0M | -$103.3M | -$52.6M |
| Revenue * | $521.3M | $336.9M | $186.4M | $77.1M | $19.1M | $0.00 | |
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | $724.0K | -$2.0M | $1.9M | -$182.0K | -$118.0K | -$46.0K | $129.0K |
| Operating Income Loss | -$22.1M | -$87.6M | -$109.2M | -$131.2M | -$173.4M | -$104.3M | -$54.7M |
| Operating Expenses | $543.4M | $424.5M | $295.5M | $208.3M | $192.6M | $104.3M | $54.7M |
| Comprehensive Income Net Of Tax | -$22.6M | -$90.0M | -$161.6M | -$135.8M | -$84.1M | -$103.3M | -$52.4M |
| Other Nonoperating Income Expense | $2.4M | $1.2M | -$2.8M | $365.0K | -$582.0K | -$192.0K | -$21.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $714.0K | -$2.1M | $1.6M | $12.0K | -$1.0K | $29.0K | -$27.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $10.0K | $130.0K | $230.0K | -$194.0K | -$117.0K | -$75.0K | $156.0K |
| Research And Development Expense Excluding Acquired In Process Cost | $186.2M | $140.6M | $102.6M | $106.8M | $131.4M | $81.6M | $43.0M |
| Income Tax Expense Benefit | $1.9M | $1.0M | $991.0K | -$6.4M | $37.0K | $6.0K | $21.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$21.4M | -$86.9M | -$162.4M | -$142.1M | -$84.0M | -$103.3M | -$52.5M |
| Selling General And Administrative Expense | $257.0M | $202.2M | $145.9M | $89.1M | $59.2M | ||
| Other Nonoperating Interest Expense | $15.1M | $16.0M | $17.6M | $335.0K | $0.00 | ||
| General And Administrative Expense | $59.2M | $22.7M | $11.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $2.9M | -$5.9M | -$14.7M | -$14.2M | -$24.6M | -$25.3M | -$23.6M | -$74.0M | -$30.1M | -$35.7M | -$26.9M | -$36.6M | -$47.1M | -$43.9M | -$50.5M | -$21.5M | -$23.3M | -$21.3M | -$15.1M | -$13.6M | -$6.0M | -$67.0K | -$10.0K |
| Revenue * | $133.0M | $127.8M | $111.6M | $90.4M | $77.9M | $69.2M | $47.7M | $37.5M | $31.6M | $18.8M | $17.5M | $12.9M | $5.0M | $11.0M | $0.00 | $0.00 | $0.00 | ||||||
| Other Comprehensive Income Loss Before Tax Portion Attributable To Parent | -$315.0K | $610.0K | $115.0K | $1.4M | -$464.0K | -$1.7M | -$1.5M | -$60.0K | $353.0K | -$211.0K | -$71.0K | -$96.0K | $7.0K | -$13.0K | -$83.0K | -$146.0K | $342.0K | -$153.0K | $70.0K | $28.0K | |||
| Operating Income Loss | $2.6M | -$5.0M | -$15.2M | -$12.7M | -$24.2M | -$26.5M | -$25.1M | -$24.3M | -$27.1M | -$32.9M | -$31.4M | -$32.7M | -$42.8M | -$37.4M | -$47.6M | -$21.7M | -$23.6M | -$22.0M | -$15.9M | -$14.0M | -$6.2M | -$65.0K | |
| Operating Expenses | $130.4M | $132.8M | $126.8M | $103.1M | $102.1M | $95.7M | $72.9M | $61.8M | $58.7M | $51.7M | $48.9M | $45.6M | $47.8M | $48.4M | $47.6M | $21.7M | $23.6M | $22.0M | $15.9M | $14.0M | $6.2M | $65.0K | |
| Comprehensive Income Net Of Tax | $2.6M | -$5.3M | -$14.6M | -$12.8M | -$25.1M | -$26.9M | -$25.1M | -$74.1M | -$29.8M | -$35.9M | -$27.0M | -$36.7M | -$47.1M | -$43.9M | -$50.6M | -$21.7M | -$22.9M | -$21.5M | -$15.0M | -$13.5M | -$6.0M | -$67.0K | |
| Other Nonoperating Income Expense | $395.0K | $86.0K | $2.1M | -$1.1M | $312.0K | $1.8M | $1.3M | -$274.0K | -$811.0K | -$192.0K | $1.3M | -$154.0K | -$35.0K | -$514.0K | -$16.0K | -$30.0K | -$56.0K | -$23.0K | -$5.0K | $9.0K | -$5.0K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$383.0K | $622.0K | $138.0K | $1.1M | -$471.0K | -$1.7M | -$1.5M | -$114.0K | $188.0K | -$20.0K | -$49.0K | -$3.0K | $0.00 | $3.0K | -$9.0K | $5.0K | $3.0K | -$4.0K | -$7.0K | -$18.0K | $0.00 | ||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $68.0K | -$12.0K | -$23.0K | $291.0K | $7.0K | $0.00 | $11.0K | $54.0K | $165.0K | -$191.0K | -$22.0K | -$93.0K | $7.0K | -$16.0K | -$74.0K | -$151.0K | $339.0K | -$149.0K | $77.0K | $46.0K | $0.00 | ||
| Research And Development Expense Excluding Acquired In Process Cost | $43.0M | $46.1M | $46.0M | $31.7M | $32.7M | $32.2M | $26.1M | $22.0M | $23.5M | $26.2M | $25.4M | $24.1M | $30.5M | $35.0M | $38.1M | $16.0M | $18.6M | $17.3M | $12.2M | $11.6M | $4.9M | ||
| Income Tax Expense Benefit | -$262.0K | $402.0K | $1.0M | $347.0K | $635.0K | $624.0K | $249.0K | $316.0K | $201.0K | $13.0K | -$6.6M | $11.0K | $9.0K | $11.0K | $5.0K | -$3.0K | $3.0K | $4.0K | $0.00 | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.6M | -$5.5M | -$13.6M | -$13.9M | -$24.0M | -$24.7M | -$23.3M | -$73.7M | -$29.9M | -$35.7M | -$33.5M | -$36.6M | -$47.1M | -$43.9M | -$50.5M | -$21.5M | -$23.2M | -$21.3M | -$15.1M | -$13.6M | -$6.0M | ||
| Selling General And Administrative Expense | $61.9M | $63.3M | $57.7M | $50.5M | $49.2M | $45.6M | $36.5M | $32.9M | $30.2M | $22.5M | $21.0M | $19.1M | $17.4M | $13.4M | $9.5M | ||||||||
| Other Nonoperating Interest Expense | $3.6M | $3.6M | $3.7M | $4.2M | $4.0M | $3.9M | $3.8M | $5.7M | $4.8M | $3.4M | $0.00 | $0.00 | $0.00 | ||||||||||
| General And Administrative Expense | $17.4M | $13.4M | $9.5M | $5.7M | $5.0M | $4.7M | $3.7M | $2.4M | $1.3M | $62.0K | $10.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $314.7M | $225.6M | $248.7M | $142.0M | $120.2M | $172.1M | $130.3M | -$17.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $298.2M | $222.9M | $286.3M | $128.0M | $131.3M | $142.1M | $12.0M | $52.0M |
| Cash And Cash Equivalents At Carrying Value | $296.7M | $222.5M | $286.3M | $28.0M | $31.3M | $142.1M | $12.0M | $52.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $75.2M | -$63.4M | $158.3M | -$3.3M | -$10.7M | $130.1M | -$40.0M | |
| Retained Earnings Accumulated Deficit | -$667.5M | -$644.2M | -$556.2M | -$392.8M | -$257.2M | -$173.2M | -$69.9M | -$17.3M |
| Prepaid Expense And Other Assets Current | $18.1M | $11.8M | $10.9M | $8.9M | $5.3M | $4.5M | $2.7M | $12.0K |
| Liabilities Current | $205.8M | $126.6M | $87.1M | $64.7M | $42.6M | $18.5M | $13.1M | $2.4M |
| Liabilities And Stockholders Equity | $842.8M | $670.8M | $646.6M | $352.9M | $294.7M | $240.9M | $146.7M | $52.0M |
| Liabilities | $528.1M | $445.1M | $398.0M | $210.9M | $174.4M | $68.8M | $16.4M | $2.4M |
| Common Stock Value | $5.0K | $5.0K | $5.0K | $4.0K | $3.0K | $3.0K | $2.0K | $1.0K |
| Assets Current | $549.7M | $392.8M | $387.5M | $190.2M | $166.6M | $236.4M | $119.4M | $52.0M |
| Assets | $842.8M | $670.8M | $646.6M | $352.9M | $294.7M | $240.9M | $146.7M | $52.0M |
| Additional Paid In Capital Common Stock | $981.9M | $870.2M | $803.3M | $535.1M | $377.4M | $345.2M | $200.1M | $34.0K |
| Accounts Payable Current | $9.6M | $14.6M | $7.4M | $8.7M | $9.2M | $3.2M | $3.4M | $269.0K |
| Property Plant And Equipment Net | $1.9M | $1.1M | $706.0K | $914.0K | $981.0K | $1.3M | $1.4M | $0.00 |
| Operating Lease Right Of Use Asset | $8.7M | $8.7M | $1.3M | $1.4M | $1.6M | $1.9M | $2.4M | |
| Other Liabilities Noncurrent | $5.0M | $2.5M | $3.8M | $4.5M | $17.0K | $29.0K | $36.0K | |
| Other Assets Noncurrent | $12.0M | $5.4M | $4.2M | $1.4M | $1.8M | $1.3M | $324.0K | |
| Operating Lease Liability Noncurrent | $7.5M | $8.0M | $617.0K | $1.3M | $1.9M | $2.6M | $3.3M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $351.0K | -$373.0K | $1.6M | -$217.0K | -$35.0K | $83.0K | $129.0K | |
| Short Term Investments | $86.6M | $57.8M | $0.00 | $123.7M | $125.2M | $89.7M | $104.7M | |
| Accrued Liabilities Current | $110.2M | $78.5M | $54.0M | $30.7M | $13.4M | $9.3M | $2.2M | |
| Operating Lease Payments | $2.6M | $1.3M | $1.1M | $911.0K | $864.0K | $576.0K | $170.0K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Liability Current | $1.7M | $1.1M | $931.0K | $711.0K | $636.0K | $397.0K | ||
| Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues | $0.00 | $0.00 | -$906.0K | $732.0K | $0.00 | |||
| Long Term Investments | $8.1M | $12.5M | $0.00 | $0.00 | $5.0M | $0.00 | $23.3M | |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.4M | $9.6M | $473.0K | $285.0K | $0.00 | $0.00 | $3.7M | |
| Intangible Assets Net Excluding Goodwill | $260.9M | $249.8M | $252.9M | $59.0M | $18.7M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $1.7M | $1.7M | $137.0K | $72.0K | $326.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $292.0M | $255.2M | $233.3M | $232.0M | $229.0M | $234.6M | $269.1M | $78.6M | $141.2M | $169.3M | $110.7M | $108.9M | $56.4M | $95.7M | $133.9M | $120.3M | $136.2M | $156.1M | $146.2M | -$34.9M | -$23.1M | -$76.0K | -$10.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $282.5M | $228.6M | $212.2M | $223.4M | $233.5M | $302.8M | $303.1M | $297.2M | $149.4M | $135.8M | $155.3M | $146.3M | $55.8M | $91.9M | $90.7M | $48.8M | $83.0M | $72.0M | $30.8M | $41.8M | $49.5M | $32.0K | ||
| Cash And Cash Equivalents At Carrying Value | $282.0M | $228.1M | $211.8M | $223.0M | $233.2M | $302.8M | $303.1M | $297.2M | $49.4M | $35.8M | $55.3M | $46.3M | $55.8M | $91.9M | $90.7M | $48.8M | $83.0M | $72.0M | $30.8M | $41.8M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.7M | $16.5M | $21.4M | $14.9M | -$51.4M | $60.1M | -$2.5M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$661.8M | -$664.7M | -$658.9M | -$620.4M | -$606.2M | -$581.5M | -$520.6M | -$497.0M | -$423.0M | -$356.4M | -$320.7M | -$293.8M | -$314.7M | -$267.6M | -$223.7M | -$136.0M | -$114.5M | -$91.2M | -$51.9M | -$36.9M | ||||
| Prepaid Expense And Other Assets Current | $23.9M | $19.1M | $14.9M | $12.1M | $8.6M | $10.0M | $12.5M | $9.7M | $9.0M | $6.9M | $3.8M | $5.9M | $6.4M | $4.5M | $4.6M | $4.4M | $2.7M | $2.9M | $3.1M | $666.0K | ||||
| Liabilities Current | $160.4M | $144.8M | $127.6M | $115.8M | $112.3M | $105.9M | $74.7M | $58.2M | $48.8M | $51.4M | $45.2M | $34.6M | $50.4M | $29.0M | $35.0M | $18.8M | $16.6M | $13.5M | $10.9M | $11.1M | ||||
| Liabilities And Stockholders Equity | $785.1M | $725.8M | $690.2M | $667.9M | $660.8M | $652.0M | $650.6M | $443.6M | $333.5M | $364.3M | $297.2M | $278.1M | $235.2M | $247.7M | $222.2M | $141.9M | $155.8M | $172.8M | $158.3M | $104.3M | ||||
| Liabilities | $493.1M | $470.7M | $457.0M | $435.9M | $431.8M | $417.4M | $381.6M | $365.0M | $192.4M | $195.1M | $186.5M | $169.2M | $178.8M | $151.9M | $88.4M | $21.6M | $19.6M | $16.7M | $12.1M | $12.4M | ||||
| Common Stock Value | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $1.0K | ||||
| Assets Current | $530.6M | $453.4M | $410.8M | $386.6M | $367.8M | $389.5M | $388.6M | $383.5M | $172.3M | $215.6M | $147.2M | $155.3M | $196.8M | $228.4M | $217.8M | $138.2M | $152.1M | $162.4M | $129.3M | $84.9M | ||||
| Assets | $785.1M | $725.8M | $690.2M | $667.9M | $660.8M | $652.0M | $650.6M | $443.6M | $333.5M | $364.3M | $297.2M | $278.1M | $235.2M | $247.7M | $222.2M | $141.9M | $155.8M | $172.8M | $158.3M | $104.3M | ||||
| Additional Paid In Capital Common Stock | $953.8M | $919.5M | $892.4M | $851.5M | $835.6M | $816.1M | $791.1M | $575.5M | $564.0M | $526.1M | $431.6M | $402.8M | $371.1M | $363.3M | $357.6M | $256.0M | $250.3M | $247.4M | $198.1M | $1.9M | ||||
| Accounts Payable Current | $12.2M | $17.7M | $11.6M | $9.5M | $9.8M | $16.0M | $7.4M | $14.4M | $6.4M | $10.5M | $8.1M | $4.9M | $5.0M | $5.4M | $5.7M | $5.2M | $3.0M | $3.3M | $2.7M | $2.3M | ||||
| Property Plant And Equipment Net | $1.3M | $1.2M | $1.1M | $1.2M | $1.1M | $501.0K | $787.0K | $866.0K | $877.0K | $795.0K | $832.0K | $898.0K | $1.1M | $1.1M | $1.2M | $1.3M | $1.4M | $1.4M | $631.0K | $460.0K | ||||
| Operating Lease Right Of Use Asset | $8.5M | $8.9M | $7.7M | $9.1M | $8.8M | $680.0K | $1.4M | $1.6M | $1.3M | $1.3M | $1.5M | $1.7M | $1.8M | $1.9M | $2.0M | $2.1M | $2.3M | $941.0K | $969.0K | |||||
| Other Liabilities Noncurrent | $16.0M | $9.1M | $13.9M | $4.0M | $4.0M | $4.3M | $7.0K | $10.0K | $772.0K | $4.3M | $4.1M | $10.0K | $19.0K | $22.0K | $24.0K | $30.0K | $31.0K | $34.0K | $37.0K | $42.0K | ||||
| Other Assets Noncurrent | $9.9M | $6.8M | $5.5M | $5.4M | $4.0M | $3.9M | $1.5M | $1.2M | $1.3M | $1.7M | $1.7M | $2.0M | $1.6M | $1.4M | $1.4M | $336.0K | $161.0K | $160.0K | $84.0K | $1.9M | ||||
| Operating Lease Liability Noncurrent | $7.4M | $7.9M | $7.0M | $8.5M | $8.2M | $328.0K | $868.0K | $1.2M | $1.1M | $1.3M | $1.5M | $1.7M | $2.1M | $2.3M | $2.5M | $2.8M | $2.9M | $3.1M | $1.1M | $1.2M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $37.0K | $352.0K | -$258.0K | $920.0K | -$477.0K | -$13.0K | -$1.5M | $76.0K | $136.0K | -$413.0K | -$202.0K | -$131.0K | -$6.0K | -$13.0K | $0.00 | $172.0K | $318.0K | -$24.0K | $98.0K | $28.0K | ||||
| Short Term Investments | $93.5M | $76.4M | $65.9M | $61.5M | $45.1M | $3.0M | $32.7M | $82.7M | $149.6M | $69.7M | $93.6M | $134.2M | $131.9M | $122.4M | $85.0M | $66.3M | $87.5M | $95.4M | $42.4M | |||||
| Accrued Liabilities Current | $104.7M | $101.4M | $89.6M | $66.2M | $42.7M | $40.4M | $38.3M | $34.5M | $26.9M | $43.8M | $20.8M | $27.8M | $13.0M | $13.0M | $9.8M | $7.9M | $8.5M | |||||||
| Operating Lease Payments | $583.0K | $289.0K | $262.0K | $219.0K | $212.0K | $107.0K | ||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Operating Lease Liability Current | $1.5M | $1.1M | $358.0K | $1.1M | $1.1M | $914.0K | $775.0K | $752.0K | $731.0K | $690.0K | $671.0K | $653.0K | $616.0K | $530.0K | $511.0K | $332.0K | $221.0K | |||||||
| Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues | $0.00 | $0.00 | $0.00 | -$232.0K | $0.00 | -$1.4M | $1.3M | -$334.0K | $0.00 | $0.00 | $0.00 | |||||||||||||
| Long Term Investments | $2.5M | $17.1M | $20.9M | $9.3M | $17.1M | $0.00 | $0.00 | $0.00 | $15.0M | $15.0M | $0.00 | $0.00 | $6.5M | $27.3M | $16.1M | |||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $1.3M | ||||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $231.9M | $237.9M | $243.8M | $255.8M | $261.8M | $257.4M | $258.3M | $56.4M | $57.7M | $45.0M | $46.1M | $18.5M | $19.0M | $0.00 | ||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $829.0K | $45.0K | -$6.0K | $52.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $55.8M | $10.3M | -$70.9M | -$120.1M | -$132.8M | -$89.1M | -$39.4M |
| Net Cash Provided By Used In Financing Activities | $40.1M | $17.7M | $336.6M | $109.1M | $73.5M | $181.3M | $127.2M |
| Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities | $50.1M | $40.3M | $30.8M | $7.6M | $22.7M | $3.7M | $10.1M |
| Share Based Compensation | $71.4M | $48.4M | $35.0M | $27.0M | $23.1M | $12.6M | $6.1M |
| Net Cash Provided By Used In Investing Activities | -$24.0M | -$90.1M | -$107.2M | $7.7M | $48.5M | $37.9M | -$127.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.8M | $849.0K | $3.6M | $3.7M | $4.0M | $1.8M | $2.7M |
| Payments To Acquire Property Plant And Equipment | $954.0K | $993.0K | $109.0K | $278.0K | $24.0K | $225.0K | $281.0K |
| Increase Decrease In Operating Lease Liability | -$1.9M | -$782.0K | -$940.0K | -$711.0K | -$649.0K | -$385.0K | -$51.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.2M | -$1.3M | -$133.0K | $12.0K | -$1.0K | $29.0K | -$27.0K |
| Depreciation Depletion And Amortization | $24.2M | $23.6M | $10.8M | $3.2M | $595.0K | $305.0K | $139.0K |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $74.4M | $19.9M | $153.0M | $140.3M | $155.6M | $85.9M | $24.5M |
| Payments To Acquire Investments | $97.4M | $89.0M | $27.3M | $132.3M | $198.0M | $74.6M | $152.0M |
| Increase Decrease In Other Operating Assets | $5.7M | $1.5M | $511.0K | $127.0K | $519.0K | -$954.0K | $160.0K |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 40.1M | 17.7M | 10.5M | 7.3M | 2.1M | 784.0K | 0.00 |
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $14.5M | $21.3M | $0.00 | $0.00 | |
| Increase Decrease In Inventories | $8.4M | $3.2M | $974.0K | $3.4M | $495.0K | $0.00 | |
| Increase Decrease In Accounts Receivable | $48.1M | $11.4M | $44.0M | $20.7M | $0.00 | ||
| Proceeds From Issuance Initial Public Offering | $0.00 | $0.00 | $86.1M | $6.9M | $121.1M | $67.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.0M | $15.2M | -$18.8M | -$39.7M | -$25.2M | -$18.4M | -$2.4M |
| Net Cash Provided By Used In Financing Activities | $6.4M | $1.2M | $13.0M | $18.1M | $6.6M | $44.7M | $0.00 |
| Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities | $11.7M | $11.3M | -$1.2M | -$8.1M | $17.2M | $476.0K | $3.7M |
| Share Based Compensation | $15.8M | $11.5M | $8.6M | $6.6M | $5.3M | $2.6M | $218.0K |
| Net Cash Provided By Used In Investing Activities | -$16.1M | -$13.0K | $27.0M | $36.5M | -$32.8M | $33.8M | -$44.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.0M | -$918.0K | $40.0K | $637.0K | $112.0K | $158.0K | $251.0K |
| Payments To Acquire Property Plant And Equipment | $41.0K | $13.0K | $41.0K | $0.00 | $3.0K | $98.0K | $44.0K |
| Increase Decrease In Operating Lease Liability | -$408.0K | -$269.0K | -$219.0K | -$170.0K | -$157.0K | $36.0K | $17.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.1M | $113.0K | $188.0K | -$3.0K | -$9.0K | -$4.0K | $0.00 |
| Depreciation Depletion And Amortization | $6.1M | $5.7M | $1.3M | $342.0K | $90.0K | $73.0K | $0.00 |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $17.4M | $0.00 | $64.5M | $36.5M | $48.6M | $29.5M | $0.00 |
| Payments To Acquire Investments | $33.5M | $0.00 | $22.4M | $0.00 | $83.4M | $0.00 | |
| Increase Decrease In Other Operating Assets | $92.0K | -$11.0K | -$285.0K | $247.0K | $160.0K | $0.00 | $125.0K |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 6.4M | 1.2M | 1.4M | 1.5M | 80.0K | 0.00 | |
| Proceeds From Issuance Of Common Stock | $0.00 | $14.5M | $0.00 | $44.7M | $0.00 | ||
| Increase Decrease In Inventories | $2.7M | $964.0K | $778.0K | $67.0K | $0.00 | ||
| Increase Decrease In Accounts Receivable | $16.8M | -$13.0M | $667.0K | $4.6M | $0.00 | ||
| Proceeds From Issuance Initial Public Offering | $0.00 | $17.4M | $6.9M | $44.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.47 | -$1.85 | -$4.00 | -$4.02 | -$2.77 | -$4.09 | -$4.58 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 180.0M |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 51.9M | 48.3M | 46.7M | 37.0M | 30.6M | 29.8M | 22.6M | 636.7K |
| Common Stock Shares Issued | 51.9M | 48.3M | 46.7M | 37.0M | 30.7M | 30.0M | 23.0M | 1.2M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 50.2M | 47.5M | 40.9M | 33.8M | 30.3M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 50.2M | 47.5M | 40.9M | 34.0M | 30.3M | |||
| Earnings Per Share Basic | $-0.47 | $-1.85 | $-4.00 | $-4.01 | $-2.77 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.3M | 25.3M | 11.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.05 | -$0.12 | -$0.30 | -$0.30 | -$0.52 | -$0.54 | -$0.57 | -$1.94 | -$0.80 | -$1.02 | -$0.84 | -$1.17 | -$1.55 | -$1.45 | -$1.68 | -$0.86 | -$0.93 | -$0.86 | -$0.84 | -$5.31 | -$2.37 | -$0.14 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 180.0M | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 51.3M | 50.1M | 49.5M | 48.0M | 47.6M | 47.1M | 46.6M | 38.2M | 38.0M | 36.8M | 32.7M | 31.7M | 30.4M | 30.3M | 30.2M | 25.2M | 25.1M | 25.0M | 22.6M | 705.3K | |||
| Common Stock Shares Issued | 51.3M | 50.1M | 49.5M | 48.0M | 47.6M | 47.1M | 46.6M | 38.2M | 38.0M | 36.8M | 32.7M | 31.8M | 30.6M | 30.5M | 30.4M | 25.5M | 25.4M | 25.4M | 23.0M | 1.2M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 50.6M | 49.7M | 48.9M | 47.8M | 47.2M | 46.9M | 41.1M | 38.1M | 37.7M | 34.9M | 32.2M | 31.3M | 30.4M | 30.3M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 57.0M | 49.7M | 48.9M | 47.8M | 47.2M | 46.9M | 41.1M | 38.1M | 37.7M | 34.9M | 32.2M | 31.3M | 30.4M | 30.3M | |||||||||
| Earnings Per Share Basic | $0.06 | $-0.12 | $-0.30 | $-0.30 | $-0.52 | $-0.54 | $-0.57 | $-1.94 | $-0.80 | $-1.02 | $-0.84 | $-1.17 | $-1.55 | $-1.45 | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 31.3M | 30.4M | 30.3M | 30.1M | 25.1M | 25.1M | 24.7M | 18.0M | 2.6M | 2.5M | 476.9K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $71.5M | $49.2M | $35.8M | $27.4M | $23.1M | $12.6M | $6.1M |
| Investment Income Interest | $12.7M | $13.8M | $13.7M | $3.9M | $366.0K | $1.6M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.2M | $18.5M | $15.8M | $12.0M | $12.2M | $11.7M | $8.6M | $8.6M | $8.7M | $7.1M | $6.8M | $6.6M | $7.4M | $4.8M | $5.3M | $3.4M | $3.0M | $2.6M | $2.1M | $1.6M | $218.0K |
| Investment Income Interest | $3.3M | $3.0M | $3.0M | $3.5M | $3.5M | $3.6M | $4.1M | $3.6M | $2.3M | $1.4M | $293.0K | $69.0K | $72.0K | $80.0K | $149.0K | $237.0K | $405.0K | $749.0K | $785.0K | $468.0K | $232.0K |
Most recent annual filing with the SEC: February 25, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.